Where is the treatment of bladder cancer more affordable

Update Date: Source: Network

summary

I had an early stage of bladder cancer. Two years ago, I had an electric resection. After two years of intravesical instillation of pirarubicin, I now have a cystoscopy. No abnormality was found. After taking the medicine for two days, I obviously feel that it has improved. Now I'd like to share with you the benefits of treating bladder cancer. It's my experience.

Where is the treatment of bladder cancer more affordable

The first factor affecting the price: the therapeutic effect depends on the stage of the disease, the depth of invasion and the scope of spread of the bladder cancer. For early bladder cancer, general partial gastrectomy. If there is local lymph node metastasis, it should be cleaned at the same time. For advanced patients, if there is no distant metastasis, surgical resection should be performed as far as possible, with the cost ranging from 20000 to 30000 yuan.

The second factor affecting the price: Patients with early bladder cancer and without any metastasis usually do not need chemotherapy after operation. Early stage bladder cancer with metastatic lymph node tumor and all advanced bladder cancer need adjuvant chemotherapy. The cost of chemotherapy varies from 1000 to tens of thousands at a time, mainly depending on the chemotherapy regimen used.

The third factor affecting price: low radiosensitivity of bladder cancer. It can't be cured by radiotherapy alone, its effect is mainly adjuvant or palliative. The main forms of radiotherapy for bladder cancer include preoperative radiotherapy, intraoperative radiotherapy, postoperative radiotherapy and palliative radiotherapy. Although the effect is good, its side effects are also very obvious, bringing multiple injuries to patients, and the cost depends on the specific situation.

matters needing attention

Bladder tumor may be accompanied by renal pelvis, ureter and urethra tumor successively or simultaneously. The incidence rate of bladder tumor is only second in male urogenital tumors, and the highest in the country. The incidence rate of male is about 3~4 times that of women, and the age is 50~70. 95% of the cases were epithelial tumors, and more than 90% of them were transitional cell carcinoma.